News Repligen Corporation

Equities

RGEN

US7599161095

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-06 pm EST			5-day change	1st Jan Change
142.18 ^USD	+1.80%		-4.81%	-13.23%

Jan. 16	UBS Adjusts Price Target on Repligen to $200 From $190, Maintains Buy Rating	MT
Jan. 13	Repligen Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 02:15 PM

Jan. 16	UBS Adjusts Price Target on Repligen to $200 From $190, Maintains Buy Rating	MT
Jan. 13	Repligen Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 02:15 PM
Jan. 13	Repligen : J.P. Morgan 2026 Healthcare Conference Repligen Presentation - J.P. Morgan 2026 Healthcare Conference	PU
Jan. 13	Repligen Corp. Seeks M&A Opportunities	CI
Jan. 06	Repligen Corporation Announces Executive Changes, Effective March 13, 2026	CI
Jan. 06	Repligen Names Martin Madaus as Board Chair	MT
Jan. 06	Repligen executive chair Tony Hunt to retire; Dr. Martin D. Madaus elected chair	RE
Jan. 06	Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair	AQ
Dec. 18	Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference	AQ
Dec. 16	Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows	AQ
Dec. 16	Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows	CI
Dec. 03	Repligen Corporation Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 01:20 PM
Nov. 26	Repligen Corporation to Present at Evercore Healthcare Conference	AQ
Nov. 19	Stocks to Watch : Nvidia, Kulicke & Soffa, Regeneron	DJ
Nov. 18	Repligen Corporation Presents at 7th Annual Wolfe Research Healthcare Conference, Nov-18-2025 12:40 PM
Nov. 18	Repligen Corporation Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 01:30 PM
Nov. 14	Repligen Insider Sold Shares Worth $3,092,278, According to a Recent SEC Filing	MT
Nov. 11	Repligen Corporation Presents at Stifel 2025 Healthcare Conference, Nov-11-2025 10:00 AM
Nov. 10	Repligen Corporation Presents at UBS Global Healthcare Conference 2025, Nov-10-2025 11:00 AM
Nov. 04	Tranche Update on Repligen Corporation's Equity Buyback Plan announced on June 18, 2008.	CI
Nov. 04	Tranche Update on Repligen Corporation's Equity Buyback Plan announced on December 7, 2023.	CI
Nov. 04	Repligen Corporation to Present at Upcoming November Conferences	AQ
25-10-28	Repligen Corporation Updates Financial Guidance for the Full Year Ending December 31, 2025	CI
25-10-28	Repligen Corporation, Q3 2025 Earnings Call, Oct 28, 2025
25-10-28	Repligen Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

News Repligen Corporation

Equities

RGEN

US7599161095

Medical Equipment, Supplies & Distribution

Filters